MedPath
NMPA Approval

Dabrafenib mesylate capsules

国药准字HJ20190066

September 10, 2024

H20190066

Drug Information

甲磺酸达拉非尼胶囊

泰菲乐

胶囊剂

75mg(以C₂₃H₂₀F₃N₅O₂S₂计)

化学药品

September 10, 2024

September 9, 2029

Company Information

Applicant Company

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

Manufacturing Company

siegfried barbera, s.l.; novartis pharmaceutical manufacturing llc

Ronda de Santa Maria,158 08210,Barberà del Vallès Barcelona Spain; Verovskova ulica 57 1000 Ljubljana Slovenia

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸达拉非尼胶囊 - NMPA 批准文号 | MedPath